The merger & acquisition frenzy that consumed the medical device industry during the 2nd quarter stayed strong during the ensuing period, although the value of the Q3 deals slipped a bit, according to PricewaterhouseCoopers.
PricewaterhouseCoopers (PwC)
Five major factors will determine the future of the medical device industry | Medtech Wall Street news for the week of October 20, 2014
Medtech VC deals post double-digit increases in Q3
Wearable Intelligence pursues $8.4 million in support of its hospital Google Glass platform | Medtech funding for the week of August 25, 2014
Funding: Medtech VC jumps in Q2, but not for early-stage companies
Life science venture capital funding saw a major boost in the 2nd quarter as public markets smiled on biotech companies, but medical device makers saw a significant boost of their own – as long as they weren’t early-stage firms.
Are device makers falling behind in the digital revolution?
The healthcare space is getting a major influx of digital innovation, but much of it’s coming from outside the traditional parameters of the industry.
May 2014 medical device recalls | Regulatory news for the week of June 9, 2014
Medical device recalls for May 2014
June 3, 2014 by MassDevice staff
May Summary
Class I recalls: 9
Class II recalls: 137
Unique Device Identifiers: 4 tips for compliance
Deadlines are fast approaching for medical device makers to unveil their Unique Device Identifier compliance programs and, if last year’s survey results are any indication, many companies are unprepared.
When PricewaterhouseCoopers surveyed more than 300 industry participants last year, less than 1 in 5 said they were prepared for UDI implementation and 19% said that they had not even started planning their UDI programs.
Boston Scientific’s peripherals buy bad news for Cardiovascular Systems? | Medtech Wall Street news for the week of May 19, 2014
Report: Deals in the medical device sector rose 200% in Q1
Acquisition activity among medical device companies surged some 200% by value and 111% by volume during the 1st quarter compared with the same period last year, with medtech firms seeking both tuck-ins and more transformative deals aimed at navigating the new healthcare landscape, according to a PricewaterhouseCoopers report.